[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! View ALL results for your Stocks, ETFs and Funds Screeners with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Insulet Corp (PODD)

Insulet Corp (PODD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]] ([[ financialData.relativeStrengthDirection14d ]]) ([[ financialData.highPercent1y ]]) ([[ financialData.lowPercent1y ]])
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 10,612,782
  • Shares Outstanding, K 69,265
  • Annual Sales, $ 2,708 M
  • Annual Income, $ 247,100 K
  • EBIT $ 507 M
  • EBITDA $ 598 M
  • 60-Month Beta 1.13
  • Price/Sales 3.74
  • Price/Cash Flow 23.16
  • Price/Book 7.79

Options Overview Details

View History
  • Implied Volatility 52.77% (+9.22%)
  • Historical Volatility 67.01%
  • IV Percentile 94%
  • IV Rank 76.72%
  • IV High 61.83% on 04/29/26
  • IV Low 22.92% on 08/22/25
  • Expected Move (DTE 12) 10.37 (6.77%)
  • Put/Call Vol Ratio 0.77
  • Today's Volume 249
  • Volume Avg (30-Day) 525
  • Put/Call OI Ratio 0.73
  • Today's Open Interest 9,912
  • Open Int (30-Day) 8,492
  • Expected Range 142.85 to 163.59

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 25 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/26
See More
  • Average Estimate $1.37
  • Number of Estimates 7
  • High Estimate $1.50
  • Low Estimate $0.97
  • Prior Year $1.17
  • Growth Rate Est. (year over year) +17.09%

Price Performance

See More
Period Period Low Period High Performance
1-Month
140.63 +8.95%
on 05/28/26
168.59 -9.12%
on 05/06/26
-14.31 (-8.54%)
since 05/05/26
3-Month
140.63 +8.95%
on 05/28/26
241.90 -36.66%
on 03/10/26
-87.72 (-36.41%)
since 03/05/26
52-Week
140.63 +8.95%
on 05/28/26
354.88 -56.82%
on 11/20/25
-163.94 (-51.69%)
since 06/05/25

Most Recent Stories

More News
Insulet Reveals New Data Supporting Breakthrough Omnipod® 6 and Fully Closed-Loop AID Systems Designed to Improve Outcomes, Reduce Effort, and Unlock Barriers to Care

STRIVE pivotal trial shows Omnipod 6 achieved strong glycemic outcomes with fewer boluses, across age groups and diabetes types ...

PODD : 153.22 (+4.65%)
Insulet to Spotlight New Data and Innovations Demonstrating How Omnipod® Simplifies Diabetes Management and Delivers Strong Clinical Outcomes at the American Diabetes Association 86th Scientific Sessions

Presentations will feature next generation Omnipod innovations designed to reduce user effort, new algorithm data, and clinical evidence demonstrating improved time in range ...

PODD : 153.22 (+4.65%)
3 Reasons We’re Fans of Insulet (PODD)

3 Reasons We’re Fans of Insulet (PODD)

PODD : 153.22 (+4.65%)
Insulet Announces U.S. Rollout of Enhanced Omnipod® 5 Algorithm and Expands Compatibility with Abbott’s FreeStyle Libre 3 Plus Sensor

Enhanced algorithm with new 100 mg/dL Target Glucose and improved alarm handling helps users improve time in range and stay in Automated Mode longer ...

PODD : 153.22 (+4.65%)
Insulet to Participate in William Blair 46th Annual Growth Stock Conference

Insulet Corporation (NASDAQ: PODD), the global leader in tubeless insulin pump technology with its Omnipod® brand of products, today announced that management will present at the William...

PODD : 153.22 (+4.65%)
Insulet Initiates Voluntary Medical Device Correction for Certain Omnipod® Pods in the U.S. and Affected International Markets

Insulet Corporation, Inc. (NASDAQ: PODD) (“Insulet” or the “Company”) today announced a voluntary Medical Device Correction for specific lots of Omnipod ® 5, Omnipod DASH ...

PODD : 153.22 (+4.65%)
Are Wall Street Analysts Bullish on Insulet Stock?

Although Insulet has lagged the broader market over the past year, Wall Street analysts remain strongly optimistic about the company’s long-term growth prospects.

$SPX : 7,383.74 (-2.64%)
PODD : 153.22 (+4.65%)
IHI : 50.08 (+0.42%)
1 Oversold Stock Set for a Comeback and 2 That Underwhelm

1 Oversold Stock Set for a Comeback and 2 That Underwhelm

BDC : 106.22 (-4.06%)
PFSI : 81.24 (-0.36%)
PODD : 153.22 (+4.65%)
The 5 Most Interesting Analyst Questions From Insulet’s Q1 Earnings Call

The 5 Most Interesting Analyst Questions From Insulet’s Q1 Earnings Call

PODD : 153.22 (+4.65%)
Why Insulet (PODD) Stock Is Trading Up Today

Why Insulet (PODD) Stock Is Trading Up Today

PODD : 153.22 (+4.65%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 88% Sell with a Weakening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

Insulet Corporation is a leading developer, manufacturer and marketer of the Omnipod Insulin Management System. The system is equipped with a self-adhesive, small and lightweight disposable tubeless Omnipod device along with the wireless and handheld Personal Diabetes Manager (PDM). The Omnipod System...

See More

Key Turning Points

3rd Resistance Point 161.05
2nd Resistance Point 157.88
1st Resistance Point 155.55
Last Price 153.22
1st Support Level 150.05
2nd Support Level 146.88
3rd Support Level 144.55

See More

52-Week High 354.88
Fibonacci 61.8% 273.04
Fibonacci 50% 247.76
Fibonacci 38.2% 222.47
Last Price 153.22
52-Week Low 140.63

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.